Xue-Song Sun

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial

Lin-Quan Tang, Dong-Ping Chen, Ling Guo et al. · The Lancet Oncology · 2018 · 144 citations

Concurrent Chemoradiotherapy, Nedaplatin Versus Cisplatin, Medicine +10

Future of Radiotherapy in Nasopharyngeal Carcinoma

Xue-Song Sun, Xiao-Yun Li, Qiu-Yan Chen et al. · British Journal of Radiology · 2019 · 136 citations · Full text

Adaptive Radiotherapy, Tumor Biology, Artificial Intelligence +14

The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012

Xue-Song Sun, Sai‐Lan Liu, Mei-Juan Luo et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 122 citations · Full text

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response

Sai‐Lan Liu, Xue-Song Sun, Jin‐Jie Yan et al. · Radiotherapy and Oncology · 2019 · 64 citations

Medicine, Metronomic Therapy, Nasopharyngeal Carcinoma Patients +7

Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy

Xue-Song Sun, Li-Ting Liu, Sai-Lan Liu et al. · BMC Cancer · 2019 · 44 citations · Full text